| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.05 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.36 | 0.05 |